About Mei He
Mei He, Ph.D. is a tenure-track assistant professor in the Department of Pharmaceutics at the University of Florida in Gainesville. She obtained her PhD degree from the University of Alberta and postdoc training from the University of California, Berkeley. Dr. He is the Editorial Board member of Pharmaceutics and the Advisory Board Member of journal Lab on Chip (LOC). Dr. He Received NIH Maximizing Investigator’s Research Award for Early Stage Investigators in 2019, and she also received the LOC Emerging Investigator Award in 2019, Outstanding Reviewers award in 2018 and 2020 by the Lab on a Chip – The Royal Society of Chemistry. Her multiple publications received the Most Download Articles of 2016 (LOC), the Featured Cover Story of 2018 (LOC), Technology Readers Choice Award of 2018 (SLAS), and Top 100 Read Articles of 2019 (Scientific Reports from Nature Publishing Group). Dr. He’s research brings in novel microfluidic and nanotechnology for differentiating, isolating, and intravesicular loading exosomes precisely, which presents a new way for developing novel precision therapeutics and drug delivery strategies. Dr. He’s innovation leads to more than 16 pending and issued patents for licensing by multiple companies and commercialized on the market. Particularly, she founded the startup company Clara Biotech in 2018 for advancing the innovative exosome research.
Dr. He’s research focuses on precise definition and control of immunity at the molecular level to tissue level, via extracellular vesicles and exosomes -mediated delivery and biological programming strategies, which can be employed in advancing cancer immunotherapy, regenerative medicine, and precision therapeutics. The long-standing interest is to understand immunity communication and delivery for translating into novel therapeutics and treatments against cancers, autoimmune diseases, and infectious diseases which immune responses are the central player.
- 3D Printing and Biomaterials
- Cancer Immunotherapy
- Extracellular Vesicles and Exosomes for Biological Programming and Nanodelivery
- Microfluidic organ on chip
- Regenerative and Precision Therapeutics